| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 786 | 8.642 | 45.939 | 84.844 | 135.054 | 165.290 | 148.133 | 85.454 |
| Total Income - EUR | - | - | 786 | 8.703 | 45.942 | 84.853 | 135.166 | 165.293 | 148.160 | 85.475 |
| Total Expenses - EUR | - | - | 432 | 6.336 | 4.836 | 4.466 | 11.466 | 28.609 | 62.718 | 66.883 |
| Gross Profit/Loss - EUR | - | - | 354 | 2.367 | 41.105 | 80.388 | 123.700 | 136.684 | 85.442 | 18.592 |
| Net Profit/Loss - EUR | - | - | 331 | 2.108 | 39.727 | 77.950 | 120.134 | 132.975 | 84.030 | 14.228 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Monoclin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 592 | 49.947 | 98.303 | 72.980 |
| Current Assets | - | - | 2.237 | 2.525 | 40.310 | 80.907 | 133.001 | 128.412 | 57.116 | 36.509 |
| Inventories | - | - | 1.090 | 949 | 836 | 820 | 802 | 0 | 0 | 0 |
| Receivables | - | - | 77 | 0 | 12.211 | 20.235 | 45.484 | 77.397 | 42.295 | 29.022 |
| Cash | - | - | 1.070 | 1.575 | 27.263 | 59.851 | 86.714 | 51.015 | 14.821 | 7.487 |
| Shareholders Funds | - | - | 374 | 2.475 | 39.777 | 77.999 | 128.252 | 133.024 | 73.235 | 54.013 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.862 | 49 | 533 | 2.907 | 5.340 | 45.336 | 82.183 | 55.476 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Monoclin S.r.l.